Plaintiff attorneys claim the Massachusetts-based company shattered the competitive position of Pylarify, a PET imaging agent for prostate cancer. 

"We urge Congress to pass final legislation that reflects this approach and retains ACR-backed provisions that can save lives," CEO Dana Smetherman, MD, MPH, MBA, said Sept. 10. 

Founded in 2011 and based in Belgium, the AI firm offers the first software for automating brain assessments needed to administer disease therapies from Biogen and Eli Lilly. 

Biparametric prostate MRIs take significantly less time than multiparametric exams, as they do not include a contrast-enhanced sequence. This also makes the abbreviated exams more cost-friendly. 

Jamieson M. Bourque, MD, MHS, president-elect of the American Society of Nuclear Cardiology, shared the group's concerns with Cardiovascular Business. “This is going to have a highly negative impact," he said. 

The Federal Trade Commission said it sent letters to multiple large healthcare staffing agencies and employers, urging them to check noncompete contracts to ensure they do not run afoul of antitrust laws.

A network of more than 100 clinics is leveraging AI to lay off more than 175 of its 2,500 or so nonclinical staff by early November.

Consolidation of image interpretation assistance into one package can minimize costs and open the market to radiology providers who cannot afford current offerings, scientists write in Radiology.  

IRs can play a key role in kidney care using a novel, nonsurgical approach that deploys catheters and imaging guidance to create a fistula in the arm for dialysis access. 

Robert C. O’Laughlin, MD, and attorneys first took Radiation Therapy Services and its physicians to court in late 2016, citing qui tam provisions of the False Claims Act.